IL-3 is an important differentiation for factor for the development of prostaglandin E2-producing macrophages between C57BL/6 and BALB/c mice

European Journal of Immunology

Volumn 37, Issue 8, 2007, Pages 2185-2195

  Kurada, Etsushi ^a   Noguchi, Junko ^a   Doi, Takahiro ^b   Uematsu, Satoshi ^c   Akira, Sisuo ^c   Yamashita, Uki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b RIKEN   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

IL 3; Macrophage (M1 M2); Prostaglandin E2; Strain difference

Indexed keywords

COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; MESSENGER RNA; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BAGG ALBINO MOUSE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE SEQUENCE; IMMUNOREGULATION; MACROPHAGE FUNCTION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; TH1 CELL; UNINDEXED SEQUENCE; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CELL DIFFERENTIATION; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; INTERLEUKIN-3; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SPECIES SPECIFICITY;

EID: 34547914831     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737041     Document Type: Article

References (54)

1. Hsieh, C. S., Macatonia, S. E., O'Garra, A. and Murphy, K. M., T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 1995. 181: 713-721.
2. Güler, M. L., Gorham, J. D., Hsieh, C. S., Mackey, A. J., Steen, R. G., Dietrich, W. F. and Murphy, K. M., Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 1996. 271: 984-987.
3. Güler, M. L., Jacobson, N. G., Gubler, U. and Murphy, K. M., T cell genetic background determines maintenance of IL-12 signaling: Effects on BALB/c and B10.D2 T helper cell type 1 phenotype development. J. Immunol 1997 159: 1767-1774.
4. Scott P., IFN-γ modulates the early development of Thl and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 1991. 147: 3149-3155.
5. Chatelain, R., Varkila, K. and Coffman, R.L., IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 1992. 148: 1182-1187.
6. Scott, P. and Scharton, T., Interaction between the innate and the acquired immune system following infection of different mouse strains with Leishmania major. Ann. N. Y. Acad. Sci. 1994. 730: 84-92.
7. Keane-Myers, A. and Nickell, S. P., Role of IL-4 and IFN-γ in modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 1995. 155: 2020-2028.
8. Hoft, D. F., Lynch, R. G. and Kirchhoff, L. V., Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi. J. Immunol. 1993. 151: 7038-7047.
9. Autenrieth, I. B., Beer, M., Bohn, E., Kaufmann, S. H. and Heesemann, J., Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: An essential role for gamma interferon. Infect. Immun. 1994. 62: 2590-2599.
10. Kitching, A. R., Tipping, P. G. and Holdsworth, S. R., EL-12 directs severe renal injury, crescent formation and Th1 response in murine glomerulonephritis. Eur. J. Immunol. 1999. 29: 1-10.
11. - T cells in non-MHC gene-controlled predisposition toward skewing into T helper type-2 immunity in BALB/c mice. J. Immunol. 1997 158: 5698-5706.
12. + T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 1997. 6: 541-549.
13. + T cells resulting in a state of unresponsiveness to IL-12. J. Immunol. 1998. 161: 6156-6163.
14. Himmelrich, H., Launois, P., Maillard, I., Biedermann, T., Tacchini-Cottier, F., Locksley, R. M., Röcken, M. and Louis, J. A., In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J. Immunol. 2000. 164: 4819-4825.
15. Mills, C. D., Kincaid, K., Alt, J. M., Heilman M. J. and Hill, A. M., M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 2000. 164: 6166-6173.
16. Mantovani, A., Sica, A. and Locati, M., New vistas on macrophage differentiation and activation. Eur. J. Immunol. 2007. 37: 14-16.
17. 2 production and its suppressive role in Th1 activation in Th2-dominant BALB/c mice. J. Immunol. 2003. 170: 757-764.
18. Doherty, T. M. and Coffman, R. L. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major. J. Immunol. 1993. 150: 5476-5483.
19. Doherty, T. M. and Coffman R. L., Ability of macrophage subsets to transfer resistance to murine leishmaniasis is dependent on IL-12 production. Eur. J. Immunol. 1999. 29: 522-529.
20. Tadokoro, C. E. and de Almeida Abrahamsohn, I., Bone marrow-derived macrophages grown in GM-CSF or M-CSF differ in their ability to produce IL-12 and to induce IFN-γ production after stimulation with Trypanosoma cruzi antigens. Immunol. Lett. 2001. 77: 31-38.
21. Shibata, Y., Berclaz, P. Y., Chroneos, Z. C., Yoshida, M., Whitsett, J. A. and Trapnell, B. C., GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 2001. 15: 557-567.
22. Saha, B., Saini, A., Germond, R., Perrin, P. J., Harlan, D. M. and Davis, T. A., Susceptibility or resistance to Leishmania infection is dictated by the macrophages evolved under the influence of IL-3 or GM-CSF. Eur. J. Immunol. 1999. 29: 2319-2329.
23. + T cells inhibits acquisition of ability to produce IFN-γ and EL-2, but not IL-4 and IL-5. J. Immunol. 1995. 155: 4604-4612.
24. 2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 1995. 181: 775-779.
25. + T cells. J. Immunol. 1996. 156: 1722-1727.
26. 2 primes naive T cells for the production of anti-inflammatory cytokines. Eur. J. Immunol. 1997. 27: 3526-3531.
27. 2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 1998. 161: 2723-2730.
28. 2 among mouse strains: A possible mechanism to polarize Th2 type response in BALB/c mice. J. Immunol. 2000. 164: 2386-2395.
29. 2 up-regulates macrophage-derived chemokine production but suppresses IFN-inducible protein-10 production by APC. J. Immunol. 2001. 166: 1650-1658.
30. 2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J. Immunol. 2002. 168: 2255-2263.
31. 2-releasing macrophages regulate Th1 and Th2 immune responses in mice treated with heat-killed BCG. J. Leukoc. Biol. 2005. 78: 1281-1290.
32. Harris, S. G., Padilla, J., Koumas, I., Ray, D. and Phipps, R. P., Prostaglandins as modulators of immunity. Trends Immunol. 2002. 23: 144-150.
33. Jakobsson, P. J., Thorón, S., Morgenstern, R. and Samuelsson, B., identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl. Acad. Sci USA 1999. 96: 7220-7225.
34. Tanikawa, N., Ohmiya, Y., Ohkubo, H., Hashimoto, K., Kangawa, K., Kojima, M., Ito, S. and Watanabe, K., Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem. Biophys. Res. Commun. 2002. 291: 884-889.
35. 2 production by membranebound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J. Biol. Chem. 2003. 278: 37937-37947.
36. 2 biosynthesis. J. Biol. Chem. 2000. 275: 32775-32782.
37. Tanaka, Y., Takahashi, A., Watanabe, K., Takayama, K., Yahata, T., Habu, S. and Nishimura, T., A pivotal role of IL-12 in Th1-dependent mouse liver injury. Int. Immunol. 1996. 8: 569-576.
38. Ihle, J. N., Interleukin-3 and hematopoiesis. Chem. Immunol. 1992. 51: 65-106.
39. Noguchi, J., Kuroda, E. and Yamashita, U., Strain difference of murine bone marrow-derived mast cell functions. J. Leukoc. Biol. 2005. 78: 605-611.
40. Ebner, S., Hofer, S., Nguyen, V. A., Fürhapter, C., Herold, M., Fritsch, P., Heufler, C. and Romani, N., A novel role for IL-3: Human monocytes cultured in the presence of EL-3 and EL-4 differentiate into dendritic cells that produce less EL-12 and shift Th cell responses toward a Th2 cytokine pattern. J. Immunol. 2002. 168: 6199-6207.
41. 2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 2003. 4: 694-701.
42. Trebino, C. E., Eskra, J. D., Wachtmann, T. S., Perez, J. R., Carty, T. J. and Audoly, L. P., Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages. J. Biol. Chem. 2005. 280: 16579-16585.
43. Min, W., Ghosh, S. and Legyel, P., The interferon-inducible p202 protein as a modulator of transcription: Inhibition of NF-κB, c-Fos, and c-Jun activities. Mol. Cell. Biol. 1996. 16: 359-368.
44. D'Souza, S., Xin, H., Walter, S. and Choubey, D., The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression. J. Biol. Chem. 2001. 276: 298-305.
45. Choubey, D. and Kotzin, B. L., Interferon-inducible p202 in the susceptibility to systemic lupus. Front. Biosci. 2002. 7: e252-262.
46. Ma, X. Y., Wang, H., Ding, B., Zhong, H., Ghosh, S. and Lengyel, P., The interferon-inducible p202a protein modulates NF-κB activity by inhibiting the binding to DNA of p50/p65 heterodimers and p65 homodimers while enhancing the binding of p50 homodimers. J. Biol. Chem. 2003. 278: 23008-23019.
47. Garlanda, C., Hirsch, E., Bozza, S., Salustri, A., De Acetis, M., Nota, R., Maccagno, A. et al., Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002. 420: 182-186.
48. Jeannin, P., Bottazzi, B., Sironi, M., Doni, A., Rusnati, M., Presta, M., Maina, V. et al., Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 2005. 22: 551-560.
49. 2 regulation of cytokine production in atopic dermatitis. J. Immunol. 1993. 151: 3345-3352.
50. 2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or EL-12. Clin. Exp. Immunol. 1998. 111: 472-476.
51. Gonzalo, J. A., Lloyd, C. M., Wen, D., Albar, J. P., Wells, T. N., Proudfoot, A., Martinez-A, C. et al., The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J. Exp. Med. 1998. 188: 157-167.
52. 2 synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J. Immunol. 2002. 168: 5811-5816.
53. Stuehr, D. T. and Nathan, C. F., Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 1989. 169: 1543-1555.
54. Zar, J. H., Biostatistical analysis. Prentice Hall, Eaglewood Cliffs, NJ 1974